This changes everything

CarryGenes’ chromosome platform will revolutionize how we treat serious diseases.

Taking advantage of what nature is already providing

CarryGenes is a merge of technologies, a fusion of expertise in immunotherapy, biomedical sciences, and chromosome bioengineering. With a lifelong passion for science and improving human health, the team has a joint ambition to use their knowledge to help other humans.

CarryGenes in numbers

20

+

Years of experience and heritige

60

+

Phase 2/3 clinical trials

135,000

+

Patient-years of human safety data form post-marketing sources